Phosphodiesterases as Drug TargetsHOUSLAY, Miles D; CONTI, Marco; FRANCIS, Sharron H et al.Handbook of experimental pharmacology. 2011, Vol 204, issn 0171-2004, 531 p.Serial Issue

Phosphodiesterases as Targets for Intermittent ClaudicationYONGGE LIU; SHAKUR, Yasmin; KAMBAYASHI, Junichi et al.Handbook of experimental pharmacology. 2011, Vol 204, pp 211-236, issn 0171-2004, 26 p.Article

Phosphodiesterase Inhibitors: History of PharmacologySCHUDT, Christian; HATZELMANN, Armin; BEUME, Rolf et al.Handbook of experimental pharmacology. 2011, Vol 204, pp 1-46, issn 0171-2004, 46 p.Article

Phosphodiesterase Inhibition in Heart FailureMOVSESIAN, Matthew A; KUKREJA, Rakesh C.Handbook of experimental pharmacology. 2011, Vol 204, pp 237-249, issn 0171-2004, 13 p.Article

Phosphodiesterases as Targets for Modulating T-Cell ResponsesBJØRGO, Elisa; MOLTU, Kristine; TASKEN, Kjetil et al.Handbook of experimental pharmacology. 2011, Vol 204, pp 345-363, issn 0171-2004, 19 p.Article

Phosphodiesterase Inhibitors in the Treatment of Inflammatory DiseasesPAGE, C. P; SPINA, D.Handbook of experimental pharmacology. 2011, Vol 204, pp 391-414, issn 0171-2004, 24 p.Article

Phosphodiesterases: Emerging Therapeutic Targets for Neonatal Pulmonary HypertensionFARROW, Kathryn N; STEINHORN, Robin H.Handbook of experimental pharmacology. 2011, Vol 204, pp 251-277, issn 0171-2004, 27 p.Article

Role of Phosphodiesterases in Adult-Onset Pulmonary Arterial HypertensionMURRAY, F; MACLEAN, M. R; INSEL, P. A et al.Handbook of experimental pharmacology. 2011, Vol 204, pp 279-305, issn 0171-2004, 27 p.Article

Small Molecule Allosteric Modulators of Phosphodiesterase 4GURNEY, Mark E; BURGIN, Alex B; MAGNUSSON, Olafur T et al.Handbook of experimental pharmacology. 2011, Vol 204, pp 167-192, issn 0171-2004, 26 p.Article

Structural Insight into the Substrate Specificity of PhosphodiesterasesHENGMING KE; HUANCHEN WANG; MENGCHUN YE et al.Handbook of experimental pharmacology. 2011, Vol 204, pp 121-134, issn 0171-2004, 14 p.Article

Cyclic Nucleotides and Phosphodiesterases in Monocytic DifferentiationHERTZ, Angie L; BEAVO, Joseph A.Handbook of experimental pharmacology. 2011, Vol 204, pp 365-390, issn 0171-2004, 26 p.Article

Therapeutic Potential of Phosphodiesterase Inhibitors in Parasitic DiseasesSHAKUR, Yasmin; DE KONING, Harry P; HENGMING KE et al.Handbook of experimental pharmacology. 2011, Vol 204, pp 487-510, issn 0171-2004, 24 p.Article

Phosphodiesterase Inhibitors: Factors That Influence Potency, Selectivity, and ActionFRANCIS, Sharron H; HOUSLAY, Miles D; CONTI, Marco et al.Handbook of experimental pharmacology. 2011, Vol 204, pp 47-84, issn 0171-2004, 38 p.Article

Pharmacology, Clinical Efficacy, and Tolerability of Phosphodiesterase-4 Inhibitors: Impact of Human PharmacokineticsTENOR, Hermann; HATZELMANN, Armin; BEUME, Rolf et al.Handbook of experimental pharmacology. 2011, Vol 204, pp 85-119, issn 0171-2004, 35 p.Article

Treatment of Erectile Dysfunction and Lower Urinary Tract Symptoms by Phosphodiesterase InhibitorsUCKERT, Stefan; STIEF, Christian G.Handbook of experimental pharmacology. 2011, Vol 204, pp 307-322, issn 0171-2004, 16 p.Article

A Fission Yeast-Based Platform for Phosphodiesterase Inhibitor HTSs and Analyses of Phosphodiesterase ActivityDEMIRBAS, Didem; CEYHAN, Ozge; WYMAN, Arlene R et al.Handbook of experimental pharmacology. 2011, Vol 204, pp 135-149, issn 0171-2004, 15 p.Article

The GAF-Tandem Domain of Phosphodiesterase 5 as a Potential Drug TargetSCHULTZ, Joachim E; DUNKERN, Torsten; GAWLITTA-GORKA, Elvira et al.Handbook of experimental pharmacology. 2011, Vol 204, pp 151-166, issn 0171-2004, 16 p.Article

Evaluation of the Therapeutic Utility of Phosphodiesterase 5A Inhibition in the mdx Mouse Model of Duchenne Muscular DystrophyPERCIVAL, Justin M; ADAMO, Candace M; BEAVO, Joseph A et al.Handbook of experimental pharmacology. 2011, Vol 204, pp 323-344, issn 0171-2004, 22 p.Article

Phosphodiesterases in the Central Nervous System: Implications in Mood and Cognitive DisordersYING XU; ZHANG, Han-Ting; O'DONNELL, James M et al.Handbook of experimental pharmacology. 2011, Vol 204, pp 447-485, issn 0171-2004, 39 p.Article

Regulation of Endothelial Barrier Function by Cyclic Nucleotides: The Role of PhosphodiesterasesSURAPISITCHAT, James; BEAVO, Joseph A.Handbook of experimental pharmacology. 2011, Vol 204, pp 193-210, issn 0171-2004, 18 p.Article

Harnessing the Clinical Efficacy of Phosphodiesterase 4 Inhibitors in Inflammatory Lung Diseases: Dual-Selective Phosphodiesterase Inhibitors and Novel Combination TherapiesGIEMBYCZ, Mark A; NEWTON, Robert.Handbook of experimental pharmacology. 2011, Vol 204, pp 415-446, issn 0171-2004, 32 p.Article